Skip to main content
Log in

Parenteral fluoroquinolones in children with life-threatening infections

Parenterale fluorierte Chinolone zur Behandlung lebensbedrohlicher Infektionen bei Kindern

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Summary

The new fluoroquinolones have not been tested in children despite their wide spectrum ofin vitro activity and efficacy, because of an observed damage to cartilage in young animals. However, in some cases they may be life-saving. We present three pediatric patients with life threatening infections in whom the fluoroquinolones were used when other antibiotics failed: A seven-year-old boy with meningitis due to multiresistantAcinetobacter calcoaceticus, a three-year-old boy with Job's syndrome with line sepsis due toStaphylococcus epidermidis and a four month-old boy with agammaglobulinemia with mixed infection due toEscherichia coli, Pseudomonas aeruginosa, andAcinetobacter spp. All three children were cured of their infections.

Zusammenfassung

Trotz ihres breiten Wirkungsspektrums und hoher Aktivitätin vitro wurden die neuen fluorierten Chinolone bei Kindern nicht therapeutisch erprobt, da bei jungen Tieren Knoprelläsionen beobachtet wurden. Sie können in bestimmten Fällen jedoch lebensrettend sein. Wir berichten über drei Kinder mit lebensbedrohlichen Infektionen, bei denen nach Versagen anderer Antibiotika fluorierte Chinolone eingesetzt wurden: bei einem siebenjährigen Jungen, der an einer Meningitis durchAcinetobacter calcoaceticus erkrankt war, einem dreijährigen Jungen mit Kathetersepsis durchStaphyloccus epidermidis bei Job-Syndrom und einem vier Monate alten Jungen mit Agammaglobulinämie, bei dem eine Mischinfektion durchEscherichia coli, Pseudomonas aeruginosa undAcinetobacter spp. aufgetreten war. Alle drei Kinder wurden von ihrer Infektion geheilt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ingham, B., Brehthall, D., Dale, E., Mcfadlean, J. Arthopathy induced by antibacterial fused NALYL-4-pyridone-3 carboxylic acids. Toxicological Letter 1 (1977) 21–26.

    Google Scholar 

  2. Tatsomi, H., Semda, H., Yattera, S., Takemoto, Y., Yamayoshi, M., Ohhishi, K. Toxicological studies on pipemidic acid: effect on diarthrodial joints of experimental animals. J. Toxicol. Science 3 (1977) 357–367.

    Google Scholar 

  3. Ball, P. Ciprofloxacin: an overview of adverse experiences. J. Antimicrob. Chemother. 18 (1988) (Suppl. D) 187–193.

    Google Scholar 

  4. Shen, L. L., Pernet, A. G. Mechanism of DNA gyrase by analogues of nalidixic acid. Proc. Natl. Adad. Sci. USA 82 (1985) 307–311.

    Google Scholar 

  5. Chin, H. X., Neu, H. C. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 25 (1984) 319–326.

    Google Scholar 

  6. King, A., Phillips, I. The comparativein vitro activity of eight newer quinolones and nalidixic acid. J. Antimicrob. Chemother. 18 (1986) (Suppl. D) 1–20.

    Google Scholar 

  7. Paton, J. H., Reeves, D. S. Fluoroquinolone antibiotics, microbiology, pharmacokinetics and clinical use. Drugs 36 (1988) 193–228.

    Google Scholar 

  8. Kiess, W., Haas, R., Marget, W. Chloramphenicol-resistantsalmonella Tennessee osteomyelitis. Infection 12 (1984) 359.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dagan, R., Schlaeffer, F. & Einhorn, M. Parenteral fluoroquinolones in children with life-threatening infections. Infection 18, 237–238 (1990). https://doi.org/10.1007/BF01643396

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01643396

Keywords

Navigation